Dr. Gabriel ETIENNE is a Senior House Physician and coordinator of the Onco-Hematology Division at the Institut Bergonié. He graduated in Clinical Onco-Haematology and Internal Medicine from the Faculty of Medicine, University of Bordeaux in 2000 and received his PhD for the work on Imatinib resistance in 2006. Dr. ETIENNE is a member of the European Hematology Association (EHA), the French Society of Haematology, and the French Groups of CML (FI-LMC) and myeloproliferative neoplasms (FIM).
Dr. ETIENNE has authored or co-authored more than 100 articles in peer reviewed journals.